Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis
- PMID: 17382396
- DOI: 10.1016/j.ophtha.2006.12.014
Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis
Abstract
Purpose: To investigate the efficacy of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis.
Design: Prospective noncomparative case series.
Participants: Twenty-eight eyes of 28 patients with neurotrophic keratitis who were refractory to conventional treatment.
Methods: The patients with neurotrophic keraitis were treated with 20% umbilical cord serum eyedrops 6 to 10 times a day. Ophthalmic examinations including best-corrected visual acuity (VA) measurement, corneal sensitivity test, corneal fluorescein staining, and anterior segment photography were performed before and after the treatment. Concentrations of substance P, insulinlike growth factor 1 (IGF-1), and nerve growth factor (NGF) in umbilical cord serum, normal peripheral blood serum, and tears were measured.
Main outcome measures: Epithelial healing time; changes of VA and corneal sensitivity after treatment; and levels of substance P, IGF-1, and NGF in umbilical cord serum, normal peripheral blood serum, and tears.
Results: The epithelial defect healed completely in all eyes, with a mean healing time of 4.4+/-4.0 weeks. The epithelial defect healed within 2 weeks in 8 eyes (28.6%), between 2 and 4 weeks in 14 eyes (50.0%), and after 4 weeks in 6 eyes (21.4%). After treatment, VA improved by >2 lines in 17 eyes (60.7%). Mean pretreatment corneal sensitivity was 21.1+/-10.5 mm, and mean posttreatment corneal sensitivity was 24.3+/-11.7 mm (P<0.01). Mean concentrations of substance P, IGF-1, and NGF were 245.3+/-53.9 pg/ml, 239.0+/-77.1 ng/ml, and 729.7+/-72.0 pg/ml in umbilical cord serum; 169.5+/-81.0 pg/ml, 375.5+/-51.3 ng/ml, and 401.7+/-98.1 pg/ml in peripheral blood serum; and 69.8+/-24.9 pg/ml, 75.7+/-50.5 ng/ml, and 107.5+/-70.9 pg/ml in tears, respectively.
Conclusions: Umbilical cord serum contains many neurotrophic factors, and umbilical cord serum eyedrops appeared to be effective for the treatment of neurotrophic keratitis.
Similar articles
-
Autologous serum application in the treatment of neurotrophic keratopathy.Ophthalmology. 2004 Jun;111(6):1115-20. doi: 10.1016/j.ophtha.2003.10.019. Ophthalmology. 2004. PMID: 15177961
-
Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome.Cornea. 2006 Apr;25(3):268-72. doi: 10.1097/01.ico.0000183484.85636.b6. Cornea. 2006. PMID: 16633024
-
Autologous serum eyedrops in the treatment of aniridic keratopathy.Ophthalmology. 2008 Feb;115(2):262-7. doi: 10.1016/j.ophtha.2007.03.087. Epub 2007 Aug 6. Ophthalmology. 2008. PMID: 17675158
-
[The cornea: stasis and dynamics].Nippon Ganka Gakkai Zasshi. 2008 Mar;112(3):179-212; discussion 213. Nippon Ganka Gakkai Zasshi. 2008. PMID: 18411711 Review. Japanese.
-
Neurotrophic keratitis.Eye (Lond). 2003 Nov;17(8):989-95. doi: 10.1038/sj.eye.6700616. Eye (Lond). 2003. PMID: 14631406 Review.
Cited by
-
Management Strategies of Ocular Chemical Burns: Current Perspectives.Clin Ophthalmol. 2020 Sep 15;14:2687-2699. doi: 10.2147/OPTH.S235873. eCollection 2020. Clin Ophthalmol. 2020. PMID: 32982161 Free PMC article. Review.
-
Treatment of Severe Dry Eye in Stevens-Johnson Syndrome with Umbilical Cord Serum Eye Drops.Clin Ophthalmol. 2022 Dec 10;16:4089-4095. doi: 10.2147/OPTH.S385078. eCollection 2022. Clin Ophthalmol. 2022. PMID: 36532819 Free PMC article.
-
Umbilical cord blood serum therapy for the management of persistent corneal epithelial defects.Int J Ophthalmol. 2014 Oct 18;7(5):807-10. doi: 10.3980/j.issn.2222-3959.2014.05.12. eCollection 2014. Int J Ophthalmol. 2014. PMID: 25349797 Free PMC article.
-
Synergistic effect of regenerating agent plus cord blood serum eye drops for the treatment of resistant neurotrophic keratitis: a case report and a hypothesis for pathophysiologic mechanism.Int Med Case Rep J. 2015 Nov 2;8:277-81. doi: 10.2147/IMCRJ.S89968. eCollection 2015. Int Med Case Rep J. 2015. PMID: 26586967 Free PMC article.
-
Effects of Topical 1% Sodium Hyaluronate and Hydroxypropyl Methylcellulose in Treatment of Corneal Epithelial Defects.Med Hypothesis Discov Innov Ophthalmol. 2016 Winter;5(4):136-144. Med Hypothesis Discov Innov Ophthalmol. 2016. PMID: 28293662 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous